News Focus
News Focus
Replies to #83615 on Biotech Values
icon url

Biowatch

09/16/09 4:58 PM

#83617 RE: Biowatch #83615

P.S., (NYSE Amex: CVM) Did NYSE/Amex merge? Did I miss something?
icon url

DewDiligence

09/16/09 6:57 PM

#83623 RE: Biowatch #83615

CVM – Paradoxically, the fact that today’s first PR from CVM (#msg-41532409) said nothing of consequence provides a handy defense vis-à-vis SEC Reg FD.

CVM can argue that its disclosure to BioMedReports one day ahead of its disclosure to other investors (#msg-41516063) was not a violation of Reg FD because absolutely nothing in the disclosure was material. The fact that hordes of traders thought the disclosure was material is not the company’s fault, LOL.